Long-Term Safety and Efficacy of KL1333 in Adults with Primary Mitochondrial Disease
- Substances:Napazimone
Belgium- Participants:18–64 years · 65+ years
- Substances:Napazimone
- Sponsor:Pharming Technologies B.V.
Rare diseases
Investigational molecules
Locations
Back to Belgium2 092 clinical trials in Herentals, Belgium. Every trial is listed in the EU Clinical Trials Register and updated daily.
BelgiumA study of JNJ-78278343 and docetaxel compared to docetaxel and prednisone in patients with metastatic castration-resistant prostate cancer
BelgiumA study comparing AZD0486 after reduced chemotherapy versus standard chemotherapy in older or unfit patients with newly diagnosed large B-cell lymphoma
BelgiumA study to assess the safety of anumigilimab in adults with sickle cell disease
BelgiumTesting inotuzumab ozogamicin and blinatumomab with drug combination for children with relapsed precursor B-cell acute lymphoblastic leukemia
BelgiumA Study of SAB-142 to Slow the Progression of Type 1 Diabetes in Adults and Children Recently Diagnosed with the Disease
BelgiumStudy of Rilvegostomig or Pembrolizumab for First-line Treatment in Patients with PD-L1-high Metastatic Non-small Cell Lung Cancer
BelgiumStudy on Golcadomide for Patients with Relapsed or Refractory Large B-Cell Lymphoma in the Brain
BelgiumStudy of ADCE-D01 for Patients with Metastatic or Unresectable Soft Tissue Sarcoma
BelgiumStudy on the Effects of Rikkunshito on Functional Dyspepsia in Primary Care Patients
BelgiumStudy on Zanidatamab with Cisplatin and Gemcitabine for Advanced HER2 Positive Biliary Tract Cancer Patients
BelgiumStudy on Bortezomib and Drug Combination for Children with High-Risk Relapsed Acute Lymphoblastic Leukemia (ALL)
BelgiumThe busiest research cities in the country
What the registry says about research in the country
Innovative research focusing on follicular lymphoma and diffuse large B-cell lymphoma, evaluating novel therapeutic approaches against traditional treatments.
These trials aim to improve treatment outcomes for patients with various forms of lymphoma through targeted therapies.
Groundbreaking studies exploring early intervention in monoclonal gammopathy and smoldering multiple myeloma conditions.
Research focused on preventing progression to active multiple myeloma through innovative treatments.
Investigation of treatment strategies for rheumatoid arthritis, comparing conventional approaches with accelerated biological therapy access.
Comprehensive evaluation of various treatment approaches for better disease management outcomes.
Studies examining optimal approaches for PPI deprescription in patients with various gastrointestinal conditions including functional dyspepsia and reflux.
Focused on developing effective strategies for reducing long-term PPI use while maintaining symptom control.
Tell us about your condition – we search every trial in Europe and connect you with the right site.